Categories: Health

Long-term metastatic melanoma survival dramatically improves on immunotherapy: Study

Long-term data from a landmark international trial show that about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors live cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Centre investigators and colleagues.

The News Vista

Share
Published by
The News Vista

Recent Posts

Big four-tracking push! Railways to expand on 7 high-density routes – why it matters

India’s seven high-density railway routes, covering about 11,000 km, are being expanded to four tracks…

1 hour ago

Two Canadian builders turn 612,000 bottles into hurricane-resistant home

In an innovative project, builders in Nova Scotia have successfully created a house using recycled…

1 hour ago

Former Power Rangers actor robbed 43 homes as the ‘Spider-Man thief’

After suffering an injury, Yasutomo Ihara—a former Green Ranger stunt performer—found himself lured into a…

2 hours ago

Zomato bans these dishes on its platform with immediate effect

Zomato has banned analogue dairy dishes from its platform immediately. Restaurant partners must transition to…

2 hours ago